These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34629712)

  • 41. Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study.
    Barakat E; Bibok A; Rishi A; Ahmed A; Frakes JM; Hoffe SE; Armaghani AJ; Soyano AE; Costa RLB; El-Haddad G; Choi J; Kis B
    Adv Radiat Oncol; 2022; 7(1):100838. PubMed ID: 35071835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
    Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
    Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver-dominant Breast Cancer Metastasis: A Comparative Outcomes Study of Chemoembolization
    Chang J; Charalel R; Noda C; Ramaswamy R; Kim SK; Darcy M; Foltz G; Akinwande O
    Anticancer Res; 2018 May; 38(5):3063-3068. PubMed ID: 29715141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial.
    Chauhan N; Mulcahy MF; Salem R; Benson Iii AB; Boucher E; Bukovcan J; Cosgrove D; Laframboise C; Lewandowski RJ; Master F; El-Rayes B; Strosberg JR; Sze DY; Sharma RA
    JMIR Res Protoc; 2019 Jan; 8(1):e11545. PubMed ID: 30664496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma.
    Labgaa I; Tabrizian P; Titano J; Kim E; Thung SN; Florman S; Schwartz M; Melloul E
    HPB (Oxford); 2019 Nov; 21(11):1497-1504. PubMed ID: 31005494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radioembolization of hepatic tumors.
    Kennedy A
    J Gastrointest Oncol; 2014 Jun; 5(3):178-89. PubMed ID: 24982766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
    Kim DY; Han KH
    Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib.
    Teyateeti A; Mahvash A; Long J; Abdelsalam M; Avritscher R; Kaseb A; Odisio B; Ravizzini G; Surasi D; Teyateeti A; Macapinlac H; Kappadath SC
    World J Gastroenterol; 2021 Dec; 27(47):8166-8181. PubMed ID: 35068861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Vardar BU; Meram E; Karaoglu K; Liang M; Yu M; Laeseke P; Ozkan OS
    Cureus; 2022 Apr; 14(4):e23783. PubMed ID: 35518553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients.
    Yim SY; Chun HS; Lee JS; Lim JH; Kim TH; Kim BK; Kim SU; Park JY; Ahn SH; Kim GM; Won JY; Seo YS; Kim YH; Um SH; Kim DY
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radioembolization in the Setting of Systemic Therapies.
    Mabud TS; Hickey R
    Semin Intervent Radiol; 2021 Oct; 38(4):472-478. PubMed ID: 34629716
    [No Abstract]   [Full Text] [Related]  

  • 52. Elevated Angiogenic Factor Levels After Transarterial Radioembolization for Colorectal Cancer Liver Metastases May Predict a Poor Prognosis.
    Soydal Ç; Araz M; Durmaz M; Özkan E; Ergüder Bİ; Küçük NÖ; Bilgiç S; Elhan AH; Geçim İE
    Mol Imaging Radionucl Ther; 2022 Jun; 31(2):114-122. PubMed ID: 35770977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver metastases from colorectal cancer: radioembolization with systemic therapy.
    Nicolay NH; Berry DP; Sharma RA
    Nat Rev Clin Oncol; 2009 Dec; 6(12):687-97. PubMed ID: 19884901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience.
    Triviño-Ibáñez EM; Pardo Moreno P; Ciampi Dopazo JJ; Ramos-Font C; Ruiz Villaverde G; González-Flores E; Navarro Vergara PF; Rashki M; Gómez-Río M; Rodríguez-Fernández A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(4):231-238. PubMed ID: 34454892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transarterial Radioembolization (TARE) Agents beyond
    Bouvry C; Palard X; Edeline J; Ardisson V; Loyer P; Garin E; Lepareur N
    Biomed Res Int; 2018; 2018():1435302. PubMed ID: 30687734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of Yttrium-90 radioembolization in the treatment of neuroendocrine liver metastases. Long-term monitoring and impact on survival.
    Tudela-Lerma M; Orcajo-Rincón J; Ramón-Botella E; Álvarez-Luque A; González-Leyte M; Rotger-Regi A; Velasco-Sánchez E; Colón-Rodríguez A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(2):82-90. PubMed ID: 33239249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience.
    Triviño-Ibáñez EM; Pardo Moreno P; Ciampi Dopazo JJ; Ramos-Font C; Ruiz Villaverde G; González-Flores E; Navarro Vergara PF; Rashki M; Gómez-Río M; Rodríguez-Fernández A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021 Jul; ():. PubMed ID: 34294586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Locoregional Therapies of Cholangiocarcinoma.
    Sommer CM; Kauczor HU; Pereira PL
    Visc Med; 2016 Dec; 32(6):414-420. PubMed ID: 28229076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: A systematic review.
    Feretis M; Solodkyy A
    World J Gastrointest Oncol; 2020 Feb; 12(2):228-236. PubMed ID: 32104553
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.